[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.54.109. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 479
Citations 0
Surgical Innovation
August 2015

Peroral Endoscopic Myotomy for Achalasia

Author Affiliations
  • 1Department of Surgery, Boston Veterans Affairs Healthcare System, West Roxbury, Massachusetts
  • 2Department of Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
  • 3Department of Surgery, University of Buenos Aires, Dr Carlos A. Bocalandro Hospital, Buenos Aires, Argentina
  • 4Center for Esophageal Diseases, Department of Surgery, University of Chicago Pritzker School of Medicine, Chicago, Illinois
JAMA Surg. 2015;150(8):806-807. doi:10.1001/jamasurg.2015.0954

The laparoscopic Heller myotomy (LHM), the endoscopic pneumatic dilation (PD), and the endoscopic botulinum toxin type A injection have been the main treatment modalities for achalasia in the past 25 years. Peroral endoscopic myotomy (POEM) is a newer treatment modality and an important advance and innovation for the treatment of achalasia. POEM allows the endoscopic division of the muscle fibers of the lower esophagus and proximal stomach, therefore coupling the minimal invasiveness of endoscopy to the therapeutic goal of a surgical myotomy.

First Page Preview View Large
First page PDF preview
First page PDF preview
×